Please Wait...

IL-18 // Interleukin 18

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Interleukin 18 (IL-18) belongs to the IL-1 family and is produced by macrophages, dendritic cells and epithelial cells (keratinocytes). Pro-IL-18 is expressed constitutively and is then activated by caspase 1. Its receptor is IL-18R and the pro-inflammatory signaling requires the formation of a complex containing IL18, IL18R and IL-18RAP (Sims and Smith, 2010). In normal condition, IL-18 activity is lowered by high levels of IL-18 Binding Protein (IL-18BP). Binding of IL-18BP to IL-18 prevents its interaction with IL-18R. The ratio IL-18BP/IL-18 is altered in inflammatory conditions (Liang et al., 2006). Elevated levels of IL-18 have also been found to have a pertinent prognostic value in predicting cardiovascular mortality in patients with chronic kidney disease (Formanowicz et al., 2015).

Bioclinica Lab employs a manual sandwich immunoassay for the measurement of IL-18 in serum.

ADDITIONAL RESOURCES

Biomarker Menu

Download MENU

Molecular Marker Laboratory Services

Download Brochure

Alzheimer's Disease Biomarker Lab Expertise

Download Info Sheet

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @bioclinica: @CardiacSafety Consortium needs your feedback! Help make the upcoming think tank "Evaluation of #MobileTechnologies in #CV…
bioclinica (5 minutes ago)
@CardiacSafety Consortium needs your feedback! Help make the upcoming think tank "Evaluation of… https://t.co/0Oc3z6zkO8
bioclinica (10 minutes ago)
RT @CDISC: Special thanks to CDISC Member @bioclinica for hosting CDISC Public Training in Audubon, PA 2-6 Apr 2018. Register today. https:…
bioclinica (26 minutes ago)
Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil… https://t.co/77NOME2Dj7
bioclinica (Yesterday)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace… https://t.co/f9vtRpsbMW
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c… https://t.co/PAdROjo7tE
bioclinica (2 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen